Derek Maetzold

Derek Maetzold

Net worth: 6 M $ as of 30/07/2026

64 year
Health Technology
Commercial Services
Consumer Services

Profile

Derek J.
Maetzold
is the founder of Castle Biosciences, Inc., founded in 2007, where the title held is President, Chief Executive Officer & Director.
Current jobs include Director at AltheaDx, Inc. since 2021, Director at Prelude Corp.
since 2022, Director at Ocular Melanoma Foundation, and Director at IMPACT Melanoma, Inc. Former jobs include Director & Associate Director-Marketing at Amylin Pharmaceuticals, Inc. from 1996 to 1998, Senior Director-Business Development at Schering-Plough Corp.
from 1999 to 2003, Associate Director-Marketing at Sandoz Pharmaceuticals Corp.
from 1985 to 1996, Vice President-Sales & Marketing at Encysive Pharmaceuticals, Inc. from 2003 to 2008, and Account Supervisor at Integrated Communications Corp.
from 1998 to 1999.
Education includes undergraduate studies at George Mason University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
13/08/2026 209,247 ( 0.69% ) 6 M $ 30/07/2026

Derek Maetzold active positions

CompaniesPositionStart
CASTLE BIOSCIENCES, INC. Founder 31/08/2007
ALTHEADX INC Director/Board Member 25/05/2021
Director/Board Member -
Director/Board Member 01/02/2022

Former positions of Derek Maetzold

CompaniesPositionEnd
Sales & Marketing 30/04/2008
Corporate Officer/Principal 31/12/2002
Corporate Officer/Principal 31/12/1998
Director/Board Member 31/12/1997
Sandoz Pharmaceuticals Corp.
Sales & Marketing 31/12/1995
See the detail of Derek Maetzold's experience

Training of Derek Maetzold

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

69

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Sandoz Pharmaceuticals Corp.

Health Technology

Miscellaneous

  1. Stock Market
  2. Insiders
  3. Derek Maetzold